CEACAM5 and cancer: Hayashi et al. [28] demonstrated that the “no-touch” isolation technique may prevent cancer cells from being shed into the portal circulation by using mutant-allele-specific amplification, while Garcia-Olmo et al. [29] found CEA products only in one of eighteen patients who underwent conventional surgery by using RT-PCR.